← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

Funds Holding in Top 10 Value Capital Flow New & Closed Increased & Reduced Calls & Puts Put/Call Ratio

New

Increased

Maintained

Reduced

Closed

Funds Holding 3,805

Funds Holding Change +34

Funds Holding Growth +0.9%

Value $756B

Holding in Top 10 317

Top 10 Change -2

Top 10 Growth -0.6%

Value Growth +10%

New 187

Increased 1,851

Reduced 1,464

Closed 101

Capital Inflow $24.6B

Capital Outflow $19.8B

Net Capital Flow +$4.8B

Capital Flow Change +$563M

Calls $8.57B

Puts $8.63B

Net Calls -$52.7M

Put/Call Ratio 1.01